Official Title

A Multicenter, Placebo-Controlled, Double-Blind, Randomized, Parallel-Group, Phase 2b Study to Evaluate the Efficacy and Safety of Ecopipam Tablets in Children and Adolescent Subjects with Tourette's Syndrome

Study Details

This research study will examine the efficacy and safety of ecopipam in pediatric patients with Tourette's Syndrome (TS).

Principal Investigator

Dr. Kevin Black

IRB Number



1. Participants must be 6 to 17 years of age at the time of screening
2. Participants must have Tourette's Syndrome
3. Participants must exhibit both motor and vocal tics

Volunteer Information

For more information about this study, contact Volunteer for Health at: